Novotech News

  1. Novotech Appoints Dr. Yooni Kim As A New Executive Position Of Managing Director For APAC To Strengthen Global Expansion 9/11/2024

    Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.

  2. Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services 9/10/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan. This recognition underscores Novotech’s commitment to accelerating clinical development for biotech companies through innovative solutions, advanced analytics, and a comprehensive global reach.

  3. Novotech Unveils 2024 Report On Global Gastric Cancer Clinical Trials And Cutting-Edge Therapeutics 9/6/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Gastric Cancer- Global Clinical Trial Landscape (2024).

  4. Novotech Releases 2024 Report On Pancreatic Cancer Clinical Trials And Drug Development 9/5/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Pancreatic Cancer- Global Clinical Trial Landscape (2024).

  5. Transforming The Future Of Medicine With RNA-Based Therapies 8/28/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, RNA Therapies — Global Clinical Trial Landscape (2024)

  6. In-Depth Report On Global Oesophageal Cancer Clinical Trials Now Available 8/19/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Oesophageal Cancer — Global Clinical Trial Landscape.

  7. Novotech Earns Renewed Certification As An Employer Of Choice For Gender Equality 7/31/2024

    Novotech, a global biotech specialist CRO, proudly announces its continued recognition as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Equality (EOCGE) in 2024. This marks another milestone in Novotech's ongoing commitment to fostering an inclusive and equitable workplace.

  8. New Report Highlights Global Trends And Advances In Chronic Lymphocytic Leukemia Research And Treatment 7/12/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has today released a significant research report entitled Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trial Landscape.

  9. Novotech Liver Cancer Research Landscape Report Finds 1,700 Trials Initiated Globally 7/5/2024

    Novotech, a global full-service clinical Contract Research Organization (CRO) specializing in partnering with biotech companies to expedite the development of cutting-edge therapeutics across all phases, has today published a leading industry report, Liver Cancer - Global Clinical Trial Landscape.

  10. Novotech Report Analyses Epilepsy Research Trends Finding More than 4,000 Clinical Trials Conducted Globally 7/2/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Epilepsy - Global Clinical Trial Landscape.